Global Retail Pharmacy Market Forecast
- Global market for retail pharmacy worth around US$624.5 Bn (2022) expects revenue of US$1,264.2 Bn by the end of 2030
- Retail pharmacy market size to demonstrate a CAGR of 10.6% between 2023 and 2030
Quick Report Digest
- The retail pharmacy industry is significantly impacted by the growing global healthcare expenditure, which is being driven by factors including aging populations, the prevalence of chronic diseases rising, and improvements in medical technology.
- The market for retail pharmacies is expanding due to the increased emphasis on personalised medicine, which entails customising medical care for each patient based on their genetic composition.
- In 2022, the generic medications category led the retail pharmacy market. When compared to their brand-name counterparts, generic pharmaceuticals are less expensive and offer the same active ingredients.
- The drug retail category dominated the market in 2022. Drug retail refers to the direct sale and distribution of both prescription and OTC drugs to customers.
- The healthcare facilities category held the largest share in the retail pharmacy market in 2022. This market sector includes retail pharmacies where hospitals, clinics, and nursing homes buy medications and supplies for patient care.
- In 2022, the offline category dominated the market. The offline retail pharmacy category is being driven by an increase of independent and chain pharmacies, as well as the availability of prescription drugs in mass merchants and supermarkets in nations like the US, and the UK.
- The market is dominated by North America due to the presence of significant key players, rising awareness of the various respiratory illnesses like asthma and chronic obstructive pulmonary disease, and a paradigm shift among consumers toward organised players that will provide high-quality medications in this area.
- Due to the rising research and development activities, rising healthcare expenditure, and expanding government backing, Asi Pacific is anticipated to increase in the retail pharmacy market over the forecast period.
A Look Back and a Look Forward - Comparative Analysis
The drivers that will expand the pharmacy retail industry includes the growing number of people with diseases, rising healthcare costs, evolving illness profiles, creative marketing tactics, an increase in the construction of wellness centres and hospital pharmacies, and rising government support.
Throughout the historical period of 2018-2022, the market had staggered growth. The main factors that influenced the retail pharmacy market are the aging population, and the rising number of prescriptions. Moreover, the retail pharmaceutical market was significantly impacted by the COVID-19 pandemic. The crucial services that pharmacies offered during the crisis, such as COVID-19 testing and immunisation, were crucial in the response. Thus, this influenced the market growth.
In the future years, rising e-commerce site demand will present profitable chances for the pharmacy retail market. Furthermore, a lucrative opportunity for pharmacy retail outlets to meet the rising demand for speciality medications is also provided by the rising prevalence of certain disorders and the development of specialist drugs.
Key Growth Determinants
- Growing Geriatric Population
The retail pharmacy sector is significantly influenced by the aging population, which has a wide-ranging effect. Older people frequently need more medication since they are more likely to have chronic illnesses such diabetes, hypertension, arthritis, and heart disease. An ongoing need for prescription medications results from this increased medication use.
Additionally, because retail pharmacies are frequently conveniently positioned in communities, older folks can receive their drugs with less hassle and without having to drive far. Seniors who may have mobility challenges may benefit greatly from this accessibility.
Furthermore, the cost of their prescription drugs is frequently covered by health insurance policies, such as Medicare. To provide seniors affordable options, retail pharmacies closely coordinate with various insurance plans.
- The Chronic Disease Epidemic
Due to its enormous effects on the demand for medicines, healthcare products, and services, the chronic disease epidemic is a significant market driver in the retail pharmacy sector. Continual prescription medication management is necessary for the treatment of chronic disorders such diabetes, hypertension, heart disease, and respiratory ailments.
Increased demand for prescription medications owing to these illnesses' rising prevalence is propelling retail pharmacies' sales. Additionally, to manage symptoms and prevent complications, many chronic diseases necessitate strict adherence to prescription regimens. Retail pharmacies are essential for informing patients about their prescriptions, coordinating prescriptions, and providing reminders to improve adherence.
- Rising Healthcare Costs
The retail pharmacy sector is significantly influenced by rising healthcare costs. Increasing healthcare spending frequently results in greater use of medical services, including prescription drugs. Patients may be more likely to seek medical attention, which would increase the number of prescriptions written and the sales of over-the-counter (OTC) drugs.
Retail pharmacies directly benefit from the rising demand for prescription drugs. Additionally, pharmacists predict increasing income as healthcare spending rises, particularly from the sale of prescription drugs. Prescription filling accounts for a large amount of retail pharmacies' revenue, and rising healthcare costs support their financial stability and expansion.
Moreover, the management of prescription drug benefits for health insurance plans is increasingly influenced by PBMs as healthcare spending rises. They bargain medicine pricing with pharmacies and pharmaceutical firms, which impacts the success and efficiency of retail pharmacies.
Major Growth Barriers
- Strict Regulatory Framework
Health authorities and licensing agencies impose strict restrictions and compliance requirements on the pharmacy retail business, creating a challenging regulatory environment. Market participants may face difficulties adhering to these requirements due to increased expenses, drawn-out procedures, and potential legal and reputational risks.
- Strong Competition
The pharmacy retail sector is very competitive, with many local and international competitors. Competing with existing pharmacy chains, internet merchants, and other healthcare providers can be a challenge to newcomers or smaller participants in the industry. In this competitive environment, differentiating themselves, sustaining client loyalty, and assuring competitive pricing are essential problems.
Key Trends and Opportunities to Look at
- Rising Trend of eCommerce and Online Pharmacy
The retail pharmacy sector has a lot of prospects due to the rising popularity of e-commerce and online pharmacies. Online drug and health store shopping is becoming more and more popular with consumers, creating new development and expansion opportunities.
- Growing Advancement in Technology
Rapid technological improvements present prospects for streamlining pharmacy operations and improving patient care, such as electronic health records, automated dispensing systems, and tele-pharmacy services. Adopting these technology advancements can boost productivity, consumer satisfaction, and market expansion in general.
- Increased Focus on Preventive Healthcare
The demand for over-the-counter goods, vitamins, supplements, and health monitoring gadgets is boosted by consumers' increasing emphasis on wellness and preventive healthcare. Taking advantage of the growing consumer interest in self-care and preventative health measures, retail pharmacies play a crucial role in the provision of these wellness items.
How Does the Regulatory Scenario Shape this Industry?
The retail pharmacy market is significantly impacted by the regulatory environment. The market's functioning is influenced by rules established by governmental organisations and healthcare authorities, which shape the market's structure, services, and level of competition. Regulatory agencies set licensing and accreditation requirements on retail pharmacies. These criteria make sure that pharmacies adhere to strict standards for people, infrastructure, and security.
Furthermore, regulatory organisations frequently have a say in how much drugs cost and how much insurance will pay out. Retail pharmacies must comply with these rules to make sure they are paid fairly for their services and follow set pricing policies. Additionally, health information about patients must adhere to strong privacy and security laws, such as those set forth by HIPAA in the US. Retail pharmacies managing patient data must adhere to these rules.
Fairfield’s Ranking Board
Top Segments
- Generic Medications Category Takes the Charge
In 2022, the generic medications category dominated the market, and it is predicted to grow significantly over the course of the forecast period. Generic medications cost less and provide the same active ingredients as their brand-name counterparts. Generic medications are gaining popularity in the retail pharmacy industry due to their accessibility, which raises their availability and utilisation and, eventually, lowers the cost to customers.
Furthermore, the OTC medications category is expected to expand significantly. These medicines can be acquired OTC and do not require a prescription. OTC products are becoming more and more popular in the retail pharmacy industry because of their accessibility and convenience. Retail pharmacies are expanding their offering of OTC medications to accommodate the growing customer demand for OTC treatments for self-care and minor ailments.
- Drug Retail Category Continues to Dominate over Health Products
The drug retail segment dominated the market in 2022. Drug retail includes the direct distribution and sale of both prescription and OTC medications to consumers. When purchasing necessary medications and medical treatments from traditional brick-and-mortar pharmacies or internet stores, people may use this application category as their primary method.
The health products retail category is expected to grow significantly over the forecast period. Among the health and wellness products sold by health products shops include vitamins, supplements, personal care items, and medical equipment. This application category caters to the self-care and preventive healthcare solutions that customers are increasingly looking for.
- Healthcare Facilities Remain the Key End Use Area
In 2022, the market was dominated by healthcare facilities. Retail pharmacies are a part of this market segment where healthcare facilities including hospitals, clinics, and nursing homes can acquire supplies and medications for patients. The need for healthcare facilities is a significant source of income for the retail pharmacy industry and it ensures effective patient care.
Over the forecast period, a large increase in the category of consumer/patients is anticipated. This end-use group includes individuals who buy prescription drugs from retail pharmacies for their own use. They are primarily responsible for driving demand for prescription and over-the-counter medications, healthcare products, and medical equipment.
- Physical Stores Maintain the Lead Despite Online’s Surge
The offline category held most of the market share. Offline retail pharmacies offer physical premises where customers can purchase medications and medical supplies. The retail pharmacy industry trend indicates that if conventional brick-and-mortar pharmacies are to compete with the rising popularity of online pharmacies and evolving consumer preferences for digital convenience, they will need to innovate and adapt.
During the forecasted years, the online category is projected to grow at the fastest rate. Online retail pharmacies give customers the convenience of ordering prescription medications and medical supplies online. The old offline brick-and-mortar pharmacy model is being challenged by the quickly growing online pharmacy industry, thanks to tech-savvy customers seeking convenience, lower pricing, and a greater selection of items.
Regional Frontrunners
North America Boasts the Largest Retail Pharmacy Market
The market is dominated by North America because of the presence of significant key players, growing public awareness of respiratory conditions like asthma and chronic obstructive pulmonary disease, and a paradigm shift among consumers toward organised players that will offer high-quality medications in this field.
As a result of technological improvements and the demand for practical and easily available healthcare solutions, North America is also seeing a growing trend in tele-pharmacy and remote healthcare services. Retail pharmacies in this area are utilising digital platforms to provide teleconsultations, drug delivery, and prescription services, improving client convenience and safety.
Asia Pacific Develops a Highly Lucrative Market
Asia Pacific is expected to grow in the retail pharmacy market over the projected period because of increased research and development activities, rising healthcare spending, and expanding government support. Additionally, the Asia Pacific region has a long history of using traditional medicine, which includes herbal cures, and exclusive Chinese drugs.
As more people look for alternative and holistic healthcare options, retail pharmacies in this region are seeing a rise in demand for conventional healthcare products. Furthermore, pharmacies are placed carefully in these areas to close the healthcare gap and improve healthcare equity in the area.
Fairfield’s Competitive Landscape Analysis
The retail pharmacy business is very competitive, with firms fighting not only for the lowest prices but also for the best service, convenience, and patient care. Businesses must adjust to shifting consumer demands and developing technologies as the sector changes to remain competitive and address the healthcare requirements of their communities. Additionally, some pharmacy chains are vertically integrated, owning or working in conjunction with healthcare providers, insurers, or other healthcare organisations to provide complete healthcare services.
Who are the Leaders in Global Retail pharmacy Space?
- Walgreens Boots Alliance Inc.
- CVS Health Corporation
- Rite Aid Corporation
- Walmart Inc.
- Wal-Mart de México, S.A.B. de C.V.
- Costco Wholesale Corporation
- Kroger Co.
- McKesson Corporation
- Cardinal Health Inc.
- AmerisourceBergen Corporation
- Albertsons Companies
- Dirk Rossmann GmbH
- The Jean Coutu Group (PJC) Inc.
- Loblaws Inc.
- Ahold Delhaize
Significant Company Developments
Mergers & Acquisitions
- June 2021: A digital pharmacy called Medly Pharmacy has made intentions to buy the pharmacy chain Pharmaca to increase its market reach to thirty.
- May 2021: Online pharmacy PharmEasy purchased ePharmacy Medlife to increase its market share and establish a stronger presence in the sector. PharmEasy now controls 60% to 70% of the Indian ePharmacy market because of this acquisition.
- July 2019: A strategic partnership between Walgreens and the large supermarket giant Kroger was revealed. As a result of the collaboration, a special "Kroger Express" department was established in a few Kroger grocery stores that began carrying Walgreen's health and beauty products.
Distribution Agreement
- January 2021: In accordance with a strategic agreement, AmerisourceBergen Corporation (NYSE: ABC) and Walgreens Boots Alliance, Inc. (Nasdaq: WBA) have agreed to the sale of most Walgreens Boots Alliance's Alliance Healthcare businesses to AmerisourceBergen for about US$6.5 Bn, which will be paid in $6.275 billion in cash and 2 billion shares of AmerisourceBergen common stock.
An Expert’s Eye
Demand and Future Growth
The demand for retail pharmacy services is still strong, supported by several reasons that guarantee its continued expansion. The demand for prescription drugs and healthcare products is expected to remain strong due to the aging of the population, the incidence of chronic diseases, and rising healthcare spending.
Additionally, people continue to visit retail pharmacies for services like vaccines, health screenings, and individualised health consultations in addition to their prescription needs due to increasing consumer preferences for accessible, one-stop healthcare solutions.
Supply Side of the Market
According to our analysis, the US is a substantial exporter of pharmaceutical goods and has a sizable impact on the worldwide retail pharmacy business. A sizable number of pharmaceutical firms, both big and small, are based in the US. It is a significant manufacturer of healthcare products, medical gadgets, and prescription and over-the-counter drugs.
The US is a world leader in pharmaceutical R&D as well. American pharmaceutical corporations make significant investments in the search for and development of novel medications and treatments, adding to the availability of pharmaceuticals worldwide. Additionally, the US has developed trade and distribution networks that make it easier to export pharmaceutical items to several nations and areas worldwide.
Global Retail Pharmacy Market is Segmented as Below:
By Type
- Generic Medications
- Over the Counter (OTC) Medications
- Patented or Brand-name Medications
By Application
- Drug Retail
- Health Products Retail
- Equipment Retail
By End Use
- Consumer/Patients
- Healthcare Facilities
- Traditional Medicine Practitioners
By Channel
- Online
- Offline
By Geographic Coverage:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Turkey
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Egypt
- Nigeria
- Rest of Middle East & Africa
1. Executive Summary
1.1. Global Retail Pharmacy Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Retail Pharmacy Market Outlook, 2018 - 2030
3.1. Global Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Generic Medications
3.1.1.2. Over-the-Counter (OTC) Medications
3.1.1.3. Patented or Brand-name Medications
3.2. Global Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Drug Retail
3.2.1.2. Health Products Retail
3.2.1.3. Equipment Retail
3.3. Global Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Consumer/Patients
3.3.1.2. Healthcare Facilities
3.3.1.3. Traditional Medicine Practitioners
3.4. Global Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights Snacks
3.4.1.1. Online
3.4.1.2. Offline
3.5. Global Retail Pharmacy Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Retail Pharmacy Market Outlook, 2018 - 2030
4.1. North America Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Generic Medications
4.1.1.2. Over-the-Counter (OTC) Medications
4.1.1.3. Patented or Brand-name Medications
4.2. North America Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Drug Retail
4.2.1.2. Health Products Retail
4.2.1.3. Equipment Retail
4.3. North America Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Consumer/Patients
4.3.1.2. Healthcare Facilities
4.3.1.3. Traditional Medicine Practitioners
4.4. North America Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. Online
4.4.1.2. Offline
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.5.1. Key Highlights
4.5.1.1. U.S. Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
4.5.1.2. U.S. Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
4.5.1.3. U.S. Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
4.5.1.4. U.S. Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
4.5.1.5. Canada Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
4.5.1.6. Canada Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
4.5.1.7. Canada Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
4.5.1.8. Canada Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Retail Pharmacy Market Outlook, 2018 - 2030
5.1. Europe Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Generic Medications
5.1.1.2. Over the Counter (OTC) Medications
5.1.1.3. Patented or Brand-name Medications
5.2. Europe Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Drug Retail
5.2.1.2. Health Products Retail
5.2.1.3. Equipment Retail
5.3. Europe Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Consumer/Patients
5.3.1.2. Healthcare Facilities
5.3.1.3. Traditional Medicine Practitioners
5.4. Europe Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Online
5.4.1.2. Offline
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.5.1. Key Highlights
5.5.1.1. Germany Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.2. Germany Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.3. Germany Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.4. Germany Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.1.5. U.K. Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.6. U.K. Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.7. U.K. Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.8. U.K. Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.1.9. France Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.10. France Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.11. France Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.12. France Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.1.13. Italy Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.14. Italy Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.15. Italy Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.16. Italy Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.1.17. Turkey Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.18. Turkey Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.19. Turkey Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.20. Turkey Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.1.21. Russia Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.22. Russia Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.23. Russia Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.24. Russia Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.1.25. Rest of Europe Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
5.5.1.26. Rest of Europe Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
5.5.1.27. Rest of Europe Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
5.5.1.28. Rest of Europe Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Retail Pharmacy Market Outlook, 2018 - 2030
6.1. Asia Pacific Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Generic Medications
6.1.1.2. Over the Counter (OTC) Medications
6.1.1.3. Patented or Brand-name Medications
6.2. Asia Pacific Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Drug Retail
6.2.1.2. Health Products Retail
6.2.1.3. Equipment Retail
6.3. Asia Pacific Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Consumer/Patients
6.3.1.2. Healthcare Facilities
6.3.1.3. Traditional Medicine Practitioners
6.4. Asia Pacific Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. Online
6.4.1.2. Offline
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.5.1. Key Highlights
6.5.1.1. China Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
6.5.1.2. China Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
6.5.1.3. China Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
6.5.1.4. China Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
6.5.1.5. Japan Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
6.5.1.6. Japan Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
6.5.1.7. Japan Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
6.5.1.8. Japan Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
6.5.1.9. South Korea Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
6.5.1.10. South Korea Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
6.5.1.11. South Korea Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
6.5.1.12. South Korea Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
6.5.1.13. India Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
6.5.1.14. India Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
6.5.1.15. India Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
6.5.1.16. India Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
6.5.1.17. Southeast Asia Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
6.5.1.18. Southeast Asia Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
6.5.1.19. Southeast Asia Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
6.5.1.20. Southeast Asia Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
6.5.1.21. Rest of Asia Pacific Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
6.5.1.22. Rest of Asia Pacific Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
6.5.1.23. Rest of Asia Pacific Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
6.5.1.24. Rest of Asia Pacific Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Retail Pharmacy Market Outlook, 2018 - 2030
7.1. Latin America Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Generic Medications
7.1.1.2. Over the Counter (OTC) Medications
7.1.1.3. Patented or Brand-name Medications
7.2. Latin America Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Drug Retail
7.2.1.2. Health Products Retail
7.2.1.3. Equipment Retail
7.3. Latin America Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Consumer/Patients
7.3.1.2. Healthcare Facilities
7.3.1.3. Traditional Medicine Practitioners
7.4. Latin America Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Online
7.4.1.2. Offline
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.5.1. Key Highlights
7.5.1.1. Brazil Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
7.5.1.2. Brazil Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
7.5.1.3. Brazil Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
7.5.1.4. Brazil Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
7.5.1.5. Mexico Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
7.5.1.6. Mexico Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
7.5.1.7. Mexico Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
7.5.1.8. Mexico Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
7.5.1.9. Argentina Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
7.5.1.10. Argentina Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
7.5.1.11. Argentina Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
7.5.1.12. Argentina Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
7.5.1.13. Rest of Latin America Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
7.5.1.14. Rest of Latin America Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
7.5.1.15. Rest of Latin America Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
7.5.1.16. Rest of Latin America Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Retail Pharmacy Market Outlook, 2018 - 2030
8.1. Middle East & Africa Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Generic Medications
8.1.1.2. Over the Counter (OTC) Medications
8.1.1.3. Patented or Brand-name Medications
8.2. Middle East & Africa Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Drug Retail
8.2.1.2. Health Products Retail
8.2.1.3. Equipment Retail
8.3. Middle East & Africa Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Consumer/Patients
8.3.1.2. Healthcare Facilities
8.3.1.3. Traditional Medicine Practitioners
8.4. Middle East & Africa Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. Online
8.4.1.2. Offline
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.5.1. Key Highlights
8.5.1.1. GCC Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
8.5.1.2. GCC Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
8.5.1.3. GCC Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
8.5.1.4. GCC Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
8.5.1.5. South Africa Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
8.5.1.6. South Africa Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
8.5.1.7. South Africa Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
8.5.1.8. South Africa Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
8.5.1.9. Egypt Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
8.5.1.10. Egypt Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
8.5.1.11. Egypt Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
8.5.1.12. Egypt Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
8.5.1.13. Nigeria Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
8.5.1.14. Nigeria Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
8.5.1.15. Nigeria Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
8.5.1.16. Nigeria Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
8.5.1.17. Rest of Middle East & Africa Retail Pharmacy Market by Type, Value (US$ Bn), 2018 - 2030
8.5.1.18. Rest of Middle East & Africa Retail Pharmacy Market, by Application, Value (US$ Bn), 2018 - 2030
8.5.1.19. Rest of Middle East & Africa Retail Pharmacy Market, by End Use, Value (US$ Bn), 2018 - 2030
8.5.1.20. Rest of Middle East & Africa Retail Pharmacy Market, by Channel, Value (US$ Bn), 2018 - 2030
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2022
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Walgreens Boots Alliance Inc.
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. CVS Health Corporation
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Rite Aid Corporation
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Walmart Inc. (operates Walmart Pharmacy)
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Wal-Mart de México, S.A.B. de C.V. (operates Walmart pharmacies in Mexico)
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Costco Wholesale Corporation (operates Costco Pharmacy)
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Kroger Co. (operates Kroger Pharmacy)
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. McKesson Corporation
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Cardinal Health Inc.
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
9.3.10. AmerisourceBergen Corporation
9.3.10.1. Company Overview
9.3.10.2. Product Portfolio
9.3.10.3. Financial Overview
9.3.10.4. Business Strategies and Development
9.3.11. Albertsons Companies (U.S.)
9.3.11.1. Company Overview
9.3.11.2. Product Portfolio
9.3.11.3. Financial Overview
9.3.11.4. Business Strategies and Development
9.3.12. Dirk Rossmann GmbH (Germany)
9.3.12.1. Company Overview
9.3.12.2. Product Portfolio
9.3.12.3. Financial Overview
9.3.12.4. Business Strategies and Development
9.3.13. The Jean Coutu Group (PJC) Inc. (Canada)
9.3.13.1. Company Overview
9.3.13.2. Product Portfolio
9.3.13.3. Financial Overview
9.3.13.4. Business Strategies and Development
9.3.14. Loblaws Inc. (Canada)
9.3.14.1. Company Overview
9.3.14.2. Product Portfolio
9.3.14.3. Financial Overview
9.3.14.4. Business Strategies and Development
9.3.15. Ahold Delhaize (Netherlands)
9.3.15.1. Company Overview
9.3.15.2. Product Portfolio
9.3.15.3. Financial Overview
9.3.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2022 |
 |
2018 - 2022 |
 |
2023 - 2030 |
Value: US$ Million |
|
REPORT FEATURES |
DETAILS |
|
Type Coverage |
|
|
Application Coverage |
|
|
End Use Coverage |
|
|
Channel Coverage |
|
|
Geographical Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
